Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216872 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
A NA study of Alcohol Use Disorder and Alcoholism, sponsored by Brainsway.
- Recruiting
- Registry status
- NA
- Development phase
- 186
- Enrollment target
- 7
- Study locations
NCT07216872 is a NA study of Alcohol Use Disorder and Alcoholism that is actively recruiting participants, run by Brainsway. The registered enrollment target is 186 participants, below the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (43% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT07216872, a NA study of Alcohol Use Disorder and Alcoholism, is actively recruiting participants, sponsored by Brainsway.
- RECRUITING
- Registry status
- NA
- Development phase
- 186 participants
- Enrollment target
- 7
- Study locations
Study Summary
The study will compare alcohol use in two groups of subjects. One group will be assigned to the Deep TMS treatment and the other group will be assigned to the sham treatment. This is a prospective, 6-month, double blind, randomized, controlled, multi-center trial in outpatients recruited in both academic and private research centers. The study population will consist of subjects diagnosed with moderate to severe AUD. The study is comprised of three phases: 1. Pre-study Screening and Baseline Phase 2. Acute Treatment Phase and 3. Maintenance Treatment and Follow up Phase Subjects of all ethnic and gender categories, ages ranging between 18-86 years will be screened for study eligibility according to the inclusion and exclusion criteria. Subjects who meet the eligibility criteria and are willing to sign an informed consent form will be enrolled in the study. The subjects' demographic and baseline characteristics, as well as their overall medical condition will be assessed prior to treatment administration. Eligible patients will be randomized with a 1:1 ratio to one of two study groups (treatment or sham) and stratified by site. Randomization will be employed to avoid bias in the assignment of subjects to treatment group. All subjects will undergo the same treatment regimen, regardless of the assigned treatment group. The acute treatment phase will include 15 treatment visits over a period of 3-5 weeks. The Maintenance Treatment \& Follow-up phase will include one treatment visit per week from the end of the Acute Treatment Phase until the 6 month follow-up visit. At each treatment session, prior to stimulation onset, alcohol related cues will be presented to the subject. After the offset of the alcohol cue presentation, active or sham Deep TMS stimulation will be administered. The study design is directed towards a comparison between active treatment and sham, up to 4 months and 6 months follow-up. Efficacy will be assessed using the primary efficacy measure of
Conditions Studied
Interventions
- DEVICE Sham (No Treatment)
- DEVICE Deep TMS (DTMS)
Study Locations (7)
Alabama
- Alpha Neuron LLC - Tuscaloosa
California
- Kadima Neuropsychiatry - La Jolla
Florida
- DTMS Center LLC - West Palm Beach
Illinois
- Rosecrance River North - Chicago
New York
- ManuMind Interventional Psychiatry - Woodbury
West Virginia
- PsyCare - South Charleston
Other
- Soroka Medical Center - Beersheba
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 186 participants |
| Start Date | 2025-11-07 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07216872
The ClinicalTrials.gov registry entry for NCT07216872 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 186 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (43% lower). The listed sponsor is Brainsway, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham (No Treatment) is the first listed.
NCT07216872 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Alabama, California, Florida.
Frequently Asked Questions
What is clinical trial NCT07216872 about?
NCT07216872 is a clinical study titled "Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)". The study will compare alcohol use in two groups of subjects. One group will be assigned to the Deep TMS treatment and the other group will be assigned to the sham treatment. This is a prospective, 6-month, double blind, randomized, controlled, multi-center trial in outpatients recruited in both aca...
What is the current status of trial NCT07216872?
This trial is currently recruiting. It is a NA study. The enrollment target is 186 participants. The study started on 2025-11-07. Estimated completion is 2027-12-01.
What conditions does trial NCT07216872 study?
This clinical trial studies the following conditions: Alcohol Use Disorder, Alcoholism, Alcohol Abuse, Alcohol Dependence, Alcohol Abuse/Dependence.
What interventions are being tested in trial NCT07216872?
The interventions under investigation include: Sham (No Treatment) (DEVICE), Deep TMS (DTMS) (DEVICE).
Who is sponsoring clinical trial NCT07216872?
This trial is sponsored by Brainsway, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07216872 being conducted?
This trial has 7 study locations across Alabama, California, Florida, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.